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Update on the clinical effectiveness programme
F
ailure by doctors to incorporate
strong research evidence into their
clinical practice delays improve-
ment in mortality and morbidity. The
logo of the Cochrane collaboration1
(fig 1) shows the clear evidence of
benefit from the randomised controlled
trials of antenatal steroids in preterm
labour available in 1982 if studies had
been subject to meta-analysis.2 Antena-
tal steroids took over a decade after this
point to be widely incorporated into
obstetric practice despite the clear evi-
dence that neonatal mortality and sub-
sequent neurodevelopmental morbidity
were reduced.3 Similarly suboptimal
management was shown in a proportion
of children with Kawasaki disease in the
UK in 1990.4 5 Only 60% received intra-
venous gammaglobulin, some in an in-
adequate dose, despite clear evidence of
benefit from randomised controlled
trials. A further examplemight be profes-
sional advice on the sleeping position for
babiesandtheriskofcotdeath.6
There are a number of reasons for
this. First, unless doctors are practising
in a very narrow field there are just too
many peer reviewed journals to read. In
addition it is only by careful critical
appraisal that the research evidence can
be set in context of what is already
known. This is a time consuming task,
and requires a skill that not all doctors
yet possess. There is also a genuine lack
of knowledge in many medical areas,
and one of the important functions of a
guideline is to highlight research gaps.
Advances in medical knowledge from
additional research are also important in
improving clinical management.
Clinical practice guidelines are ‘‘sys-
tematically developed statements to
assist both practitioner and patient in
decisions about appropriate health care
for specific clinical circumstances’’.7 It is
only through the systematic search for
and appraisal of research evidence that
truly ‘‘evidence based’’ recommenda-
tions can be produced. Clinical guide-
lines provide assistance for a number of
decisions that together comprise a clin-
ical pathway. Many evidence based
clinical guidelines are supported by
systematic reviews of research evidence.
A systematic review is ‘‘any summary
that attempts to address a focused
clinical question using methods
designed to reduce the likelihood of
bias’’,8 Health technology assessments
critically appraise all evidence on a
specific intervention and give guidance
for its use. Both clinical guidelines and
systematic reviews can help to identify
priorities for primary clinical research.
In 1996 the Royal College of
Paediatrics and Child Health (RCPCH)
mandated the Quality of Practice
Committee (QPC) to:
‘‘act to improve clinical practice by
various means—including the pro-
duction of guidelines. These guide-
lines will be evidence based,
rigorously scrutinised by peer
groups and should be eminently
subject to audit.’’
The QPC oversees the College’s clin-
ical effectiveness programme, including
clinical guidelines, the dissemination of
systematic reviews, and clinical audit.
Any statement about clinical practice
made by or on behalf of the College is
appraised by the QPC, which then
makes recommendations to its Council.
Effectively the QPC is the ‘‘guardian’’ of
the College with regard to paediatric
practice. The College’s Health Services
Committee undertakes a similar role for
statements pertaining to the organisa-
tion or configuration of services.
However, any evidence based guidance
on clinical practice may have implica-
tions for service delivery.
An evidence based clinical practice
guideline9 10 will contain a mixture of
recommendations where there is sup-
porting evidence and others where no
research evidence exists. The College
formally recognises three categories of
statement about clinical practice (see
table 1), and has different mechanisms
for managing them.
The resources required to create a well
produced evidence based clinical guide-
line are prodigious. The QPC has devel-
oped a procedure for appraising clinical
guidelines11 to ensure that only those
produced according to best practice are
given college endorsement. This involves
checking the guideline methodology
using the AGREE instrument12 and then
reviewing all the recommendations sup-
ported by strong evidence alongside the
original publications, to confirm that
they accurately reflect the evidence.
The scope and clinical questions to be
included are crucial if a guideline is to
be useful to professionals and patients.
It must be underpinned by a fully
documented and rigorous literature
review. Each relevant research study
should be critically appraised and the
level of evidence (1–5) documented
using a system that defines a hierarchy
of evidence relevant to the type of
question. The grading system used for
recommendations (A–D) likewise cre-
ates a hierarchy dependent on both the
strength and applicability of the sup-
porting evidence. It is therefore straight-
forward for readers to judge the
strength of supporting evidence for each
recommendation. Other important fea-
tures of a clinical guideline include the
involvement of all relevant profes-
sionals, and of children and their carers,
the use of a formal consensus process
(for example, Delphi)13 where evidence
is lacking, piloting of the guideline, and
the inclusion of audit criteria, written
patient information, and educational
material. A well produced evidence
based guideline will also identify prior-
ities for further research.
At present the QPC, for resource
reasons, only appraises A and B recom-
mendations. This is being addressed as
sometimes C and D recommendations
have even more clinical relevance and
importance despite a weaker evidence
base. The College Council gives final
approval to endorse a clinical guideline.
The college standards represent best
practice but the approval process gives
a measure of discretion so that while
only well produced clinical guidelines
are endorsed, the standards have not been
set so high that they are unattainable.Figure 1 Logo of the Cochrane collaboration.
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The production of clinical guidelines
in itself does not change practice.14 In
order to do so, the barriers to change
need to be understood. A clear mes-
sage should be promoted through
multiple mechanisms (a ‘‘multi-faceted’’
approach), including championing by
leaders, educational packages, and audit.
Audit alone appears to be a weak driver
for change, whereas championing by
leaders in the field appears more effective
(using ‘‘eminence based medicine’’ to
promote ‘‘evidence based medicine’’).
Those developing a clinical guideline
should therefore consider at the outset
what are the potential barriers to imple-
mentation, and agree a supporting dis-
semination and implementation strategy
that includes relevant supporting educa-
tional material for the profession and
parents and children.
In the last five years the QPC has
identified, appraised, and disseminated
the appraisals of over 20 evidence based
clinical guidelines on a wide variety of
topics (table 2). Further guidelines are
currently being appraised. The clinical
guideline on chronic fatigue syndrome
(CFS/ME)15 is the first one to be initi-
ated and carried through entirely by the
RCPCH. The Quality of Practice Com-
mittee remained independent of the
guideline development group, and was
therefore able to undertake the quality
assurance without conflict of interest.
Not all the identified clinical guide-
lines have been endorsed in the apprai-
sal process, however: one produced
through the very reputable auspices of
the Scottish Intercollegiate Guidelines
Network (SIGN) contained significant
discrepancies between the evidence
cited and the recommendations,16
despite apparently appropriate guideline
development methodology and despite
consultation including the RCPCH. A
revised version has been published by
SIGN,17 but not appraised as the litera-
ture search was by then over five years
old. Another guideline commissioned by
the National Institute for Clinical
Excellence (NICE) on eating disorders18
gave insufficient guidance on a number
of important clinical issues for paedia-
tric practice, including differential diag-
nosis and the management of
complications. A third guideline on the
management of urinary tract infections
(from the American Academy of
Pediatrics19) showed the importance of
ensuring that the scope includes the
appropriate outcomes. Although the
RCPCH did endorse this guideline, the
QPC appraisal commented that it did
not address the link between childhood
urinary tract infections, renal abnorm-
alities, and long term outcome with or
without treatment.20 Without this link,
the recommendations for initial man-
agement of children following a urinary
tract infection could not be considered
valid. These examples illustrate some of
the potential pitfalls of clinical guideline
development, and justify the college’s
careful approach.
The Quality of Practice Committee,
through strong links with SIGN, has for
several years submitted suggestions for
future guideline topics. NICE is now
developing more evidence based clinical
guidelines for a number of child health
topics, and the QPC submits suggestions
to its Advisory Committee for Topic
Selection. The final decision about topic
selection rests with the Secretary of
State for Health and the Welsh Assem-
bly. The College has also submitted
priority topics for research identified
through clinical guideline development
to the National Coordinating Centre for
Health Technology Appraisals.
The number of new paediatric clinical
guidelines from NICE and SIGN will
increase and other reputable sources
(for example, the British Thoracic
Society) are coming on-stream.
Together with the existing evidence
based guidelines, a formidable array of
college endorsed guidelines should soon
be a reality.
The QPC approach has meant that the
RCPCH has been in a position to
endorse more clinical guidelines, from
a wide variety of sources, than would
be the case if only college initiated
Table 1 College categories of clinical practice statements
Nomenclature Characteristics College policy
Evidence based guideline l The composition of the guideline panel and its
processes are appropriate for the topic
l May endorse through the recommendation of the Quality
of Practice Committee
l There is a robust and well documented process for the
identification and synthesis of the evidence
l A copy of the QPC appraisal is circulated via the College
quarterly newsletter
l The guideline construction includes a transparent link
between the questions asked, the supporting evidence,
and the derivation of the recommendations
l The guideline appraisal is posted on the clinical
effectiveness page of the College website, together with a
hotlink to the original guideline
l May contain consensus statements (see below) l The topic may be showcased at the annual College
meeting in York
l Selected guidelines are summarised and reviewed in the
new Education and Practice supplement to Archives of
Disease in Childhood
Consensus statement l A rigorous process has shown that there is no evidence
to answer the question
l As for evidence based guidelines
l Consensus takes account of the views of all involved in
the area including nurses, doctors, professions allied to
medicine, and parent/patient groups
l A specific methodology (e.g. Delphi), prevents the more
vociferous or articulate or those with specific issues
from unduly influencing the outcome
l The consensus process is transparent
Practice statement l Absence of characteristics above l May be listed only by title on the website
l May be based on the views of a group of eminent
individuals and/or lacking clarity about the evidence
base used for its production
l Accompanying disclaimer:
‘‘Practice statements have not been developed according
to RCPCH standards. There may not have been an
appropriate stakeholder base and the evidence base may
be incomplete. There may be unforeseen cost implications,
and there may be other approaches to clinical practice
that are equally or more appropriate. Members are asked
to note these qualifications when considering them with
respect to their own practice’’
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guidelines were endorsed. So, in what
direction should the clinical guidelines
programme be developing further? It
has been suggested that the college
might start producing ‘‘best practice
guidelines or statements’’, without fol-
lowing a rigorous evidence based
approach, so as to cover an even wider
range of topics. This would run counter
to the College’s current policy, and it
could not claim to be following best
practice in relation to evidence based
medicine. It would also undermine the
College’s position relating to poorly
produced clinical guidelines submitted
to it, and weaken the authority of well
produced evidence based guidelines.
The other approach is to strengthen
the college’s mechanisms for promoting
the messages from the clinical guide-
lines already being developed. NICE has
until recently considered the implemen-
tation of its guidelines as outside its
remit. The promotional material and
mechanisms for disseminating its mes-
sages to clinicians are therefore usually
weak, and the college could assist with
this.
The guideline appraisals circulated to
College members with the College news-
letters now take the form of a summary
of the clinical guidelines including the
scope and all the recommendations.
Only the A and B recommendations
were previously included, but this has
now changed. In future the College
‘‘standards for clinical guidelines’’ will
include a stronger section on local
implementation; this should include
how to develop a local protocol/inte-
grated care pathway and how to under-
take an audit of compliance.
In addition, the College should take
the lead in planning the launch of new
guidelines, perhaps in collaboration
with guideline developers including
NICE. This could include the prepara-
tion of educational material, which
would be likely to help their local
implementation. The college needs to
state more clearly to paediatricians what
is expected of them when the college
endorses a clinical guideline: unless
they are adopted into practice the efforts
of guideline developers are wasted.
In summary, the College’s clinical
effectiveness programme, overseen by
the Quality of Practice Committee, has
already endorsed a number of evidence
based clinical guidelines, including its
first in-house guideline on chronic
fatigue syndrome (CFS/ME).15 It now
needs to focus more directly on the local
implementation and audit of well
produced guidelines, and so help
paediatricians achieve demonstrable
improvements in the quality of delivered
care.
Arch Dis Child 2005;90:888–891.
doi: 10.1136/adc.2004.064253
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BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease
A
16 week old child of Chinese origin presented with a
history of persistent fever for three days. She was very
irritable and had bright red lips and few maculopap-
ular spots on the trunk. She did not have any significant
cervical lymphadenopathy, but did have red eyes. In view of
the age a full septic screen was performed and intravenous
antibiotic was started. Investigations revealed a raised white
blood cell count, C reactive protein, erythrocyte sedimenta-
tion rate, and liver enzymes, but normal chest x ray,
cerebrospinal fluid, and urine. She continued to have a very
high spiking temperature even at 48 hours despite negative
blood culture. Subsequently marked redness with some
induration was noticed around the BCG site.
Due to the presence of fever for over five days, conjuncti-
vitis, red lips, and irritability, incomplete Kawasaki disease
was postulated. This hypothesis was further strengthened by
the development of erythema around the BCG scar.
The child was started on intravenous immunoglobulin in
accordance with a recent recommendation of the American
Heart Association.1 Fever subsided within 36 hours and the
erythema around the BCG site disappeared. Her initial
echocardiogramwas normal and she is under cardiac follow up.
Any child with irritability and persisting fever (>5 days)
not responding to antipyretics should be suspected to have
Kawasaki disease. All criteria need not be fulfilled; incom-
plete Kawasaki disease may be present.1 In view of the
reported higher incidence of coronary involvement in
infancy,2 an early diagnosis and prompt treatment are
essential. Erythema at the site of BCG inoculation is rare,
but it is a specific sign of Kawasaki disease3 and hence can be
used as a tool for an early diagnosis.
Children have been diagnosed early by looking at the BCG
scar on admission.4 This should be particularly useful
in communities where BCG vaccination is universal.
This phenomenon has been hypothetically ascribed to
cross-reactivity between mycobacterial heat shock protein
(HSP) 65 and human homologue HSP 63.5
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